EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Soluble ST2 as an Independent Predictor of Post-Discharge New-Onset Atrial Fibrillation in Patients with ST-Elevation Myocardial Infarction

Wen Li, Menghua Xu, Yicheng Shi, Debin Cao, Xiaofu Zhang, Siwen Wu, Ruijie Bao, Jinxiu Yang, Yong Li

Cardiology · 09.05.2026 · 1-10

DOI: 10.1159/000552461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology, online erschienen am 09.05.2026. Verfasst von Wen Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First People's Hospital of Yuhang District, Hangzhou, China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

New-onset atrial fibrillation (NOAF) represents a significant complication following ST-elevation myocardial infarction (STEMI). Soluble suppression of tumorigenicity 2 (sST2) is a biomarker reflecting myocardial stress and fibrosis. However, its predictive value for post-discharge NOAF in STEMI patients remains inadequately characterized. This study was to investigate whether elevated sST2 levels during hospitalization independently predict post-discharge NOAF in STEMI patients.

Methods

This multicenter, prospective cohort study enrolled 648 consecutive STEMI patients. Serum sST2 concentrations were measured within 24 h of admission using ELISA. Multivariable logistic regression, receiver operating characteristic (ROC) curve analysis, and risk reclassification metrics were employed to assess sST2’s predictive performance.

Results

NOAF occurred in 56 patients (8.64%) during follow-up. Patients developing NOAF exhibited significantly higher sST2 levels compared to those without NOAF (62.84 ± 54.62 vs. 30.37 ± 34.71 ng/mL, p < 0.001). After adjusting for confounders, sST2 remained an independent predictor of NOAF (OR = 1.02, 95% CI: 1.01–1.02, p < 0.001). The area under the ROC curve for sST2 was 0.785 (95% CI: 0.723–0.848). Incorporating sST2 into the clinical model significantly improved discrimination (AUC from 0.718 to 0.810, p < 0.001) and risk reclassification (NRI = 0.084, p = 0.033; IDI = 0.047, p = 0.003). Restricted cubic spline analysis revealed a nonlinear dose-response relationship between sST2 and NOAF risk.

Conclusion

Elevated sST2 levels during hospitalization independently predict post-discharge NOAF in STEMI patients, offering incremental prognostic value beyond traditional risk factors.

Schlagwörter

Stichwörter der Autor:innen

BiomarkerNew-onset atrial fibrillationRisk predictionST-elevation myocardial infarctionSoluble ST2

Autor:innen und Institutionen

  • Department of Cardiology, The First People's Hospital of Yuhang District, Hangzhou, China.
  • Department of Cardiology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Cardiology, The First People's Hospital of Yuhang District, Hangzhou, China, liyonghzlz@163.com.

Zitieren

APA

Li, W., Xu, M., Shi, Y., Cao, D., Zhang, X., Wu, S., Bao, R., Yang, J., & Li, Y. (2026). Soluble ST2 as an Independent Predictor of Post-Discharge New-Onset Atrial Fibrillation in Patients with ST-Elevation Myocardial Infarction. Cardiology, 1-10. https://doi.org/10.1159/000552461

Vancouver

Li W, Xu M, Shi Y, Cao D, Zhang X, Wu S, et al. Soluble ST2 as an Independent Predictor of Post-Discharge New-Onset Atrial Fibrillation in Patients with ST-Elevation Myocardial Infarction. Cardiology. 2026:1-10. doi:10.1159/000552461

BibTeX
@article{Li2026,
  author = {Li, Wen and Xu, Menghua and Shi, Yicheng and Cao, Debin and Zhang, Xiaofu and Wu, Siwen and Bao, Ruijie and Yang, Jinxiu and Li, Yong},
  title = {Soluble ST2 as an Independent Predictor of Post-Discharge New-Onset Atrial Fibrillation in Patients with ST-Elevation Myocardial Infarction},
  journal = {Cardiology},
  year = {2026},
  pages = {1--10},
  doi = {10.1159/000552461}
}
Kostenlos starten →